Abstract
The influence of the donor (D) and recipient (R) pre-transplant Epstein-Barr Virus (EBV) serostatus on transplant outcomes (overall survival, relapse-free survival, relapse incidence, non-relapse mortality, acute and chronic GVHD) in 12,931 patients with lymphomas or chronic malignancies undergoing allogeneic hematopoietic cell transplant (allo-HCT) between 1997-2016 was analyzed. In multivariate analysis, the risk of development of chronic GVHD was increased for EBV R+/D+ (HR = 1.26; p = 0.003), R+/D- (HR = 1.21; p = 0.044), and R-/D + (HR = 1.21; p = 0.048) in comparison to R-/D- transplants. No significance was shown for other transplant outcomes; however, in univariate analysis, EBV-seropositive patients receiving grafts from EBV-seropositive donors (EBV R+/D+transplants) had inferior transplant outcomes in comparison to EBV-seronegative recipients of grafts from EBV-seronegative donors (EBV R-/D-): inferior overall survival (59.6% vs 65.9%), inferior relapse-free survival (51.1% vs 57.5%), increased incidence of chronic GVHD (49.5% vs 41.8%), and increased incidence of de novo chronic GVHD (30.5% vs 24.0%). In conclusion, an EBV-negative recipient with lymphoma or chronic malignancy can benefit from selection of an EBV-neg...Continue Reading
References
Oct 1, 1974·Transplantation·H GlucksbergE D Thomas
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Aug 17, 2000·The New England Journal of Medicine·J I Cohen
Jun 20, 2008·Statistics in Medicine·Mei-Jie Zhang, Jason Fine
Dec 2, 2008·Bone Marrow Transplantation·J StyczynskiUNKNOWN Second European Conference on Infections in Leukemia
Mar 15, 2013·Bone Marrow Transplantation·Simona Iacobelli, UNKNOWN EBMT Statistical Committee
Jun 19, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan StyczynskiUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jul 1, 2014·Leukemia & Lymphoma·Satoko MorishimaYasuo Morishima
Jul 24, 2014·Blood·Ahmad KhoderKatayoun Rezvani
Jan 22, 2015·Blood·Adèle de MassonGérard Socié
Dec 22, 2015·The Lancet. Haematology·Jacopo OlivieriGiovanni Pomponio
Mar 6, 2016·Blood·Edouard ForcadeJerome Ritz
Apr 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katayoun Rezvani, Richard E Champlin
Apr 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan StyczynskiSimone Cesaro
Jul 2, 2016·Haematologica·Jan StyczynskiUNKNOWN Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the Europea
Sep 3, 2017·Blood·Florent MalardMohamad Mohty
Dec 28, 2017·The New England Journal of Medicine·Robert Zeiser, Bruce R Blazar
Mar 8, 2018·Immunology·Yu-Mei DaiWei He